Medical Science News

RSS

Researchers report on under-sequenced region of S gene of the SARS-CoV2 Delta variant

In a recent study, Swiss researchers use improved techniques to understand the biological significance behind the Delta variant.

19 Sep 2021

Specially designed lipid nanoparticles overcome resistance to anti-tumor immunotherapy

A specially designed lipid nanoparticle could deliver immune-signaling molecules into liver macrophage cells to overcome resistance to anti-tumor immunotherapy.

18 Sep 2021

R37 MERIT Award supports innovative ovarian cancer research

One of the most impactful advancements during the past decade in treating ovarian cancer is the use of PARP inhibitors (short for poly adenosine diphosphate-ribose polymerase). PARP inhibitors are a type of cancer drug that blocks the PARP enzyme from helping to repair DNA damage in cancer cells.

18 Sep 2021

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according to new research published in the New England Journal of Medicine.

18 Sep 2021

Higher white matter extracellular free-water related to cognitive dysfunction in lupus patients

Systemic lupus erythematosus (SLE) is an autoimmune disease in which the immune system attacks the body's own tissues, causing widespread inflammation and damage in the affected organs.

18 Sep 2021

Cross-species locomotion features shared by dopamine-deficient worms, mice, and humans

Scientists from the Graduate School of Information Science and Technology at Osaka University used animal location tracking along with artificial intelligence to automatically detect walking behaviors of movement disorders that are shared across species.

18 Sep 2021

Increased presence of certain bacteria in the gut may indicate colon cancer risk

A study published today in the journal Cell Host & Microbe reported that the increased presence of certain bacteria in a gut biome indicates a greater likelihood that colon polyps will become cancerous.

18 Sep 2021

Research reveals a possible new treatment approach for pediatric rhabdomyosarcoma

Scientists at St. Jude Children's Research Hospital have revealed how the tumor suppressor gene PTEN plays a more important role in pediatric rhabdomyosarcoma than was previously appreciated.

18 Sep 2021

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.

18 Sep 2021

Two-hour glucose tolerance test helps identify patients at heightened risk of cognitive decline

Diabetes is a risk factor for cognitive decline. In a study of the University of Turku and Finnish Institute for Health and Welfare, the researchers observed that already a higher two-hour glucose level in the glucose tolerance test predicts worse performance in a test measuring episodic memory after ten years.

18 Sep 2021

What pushed Israel out of herd immunity?

Scientists have recently tried to explain the factors that could be responsible for the recent outbreaks of COVID-19 in Israel.

17 Sep 2021

Humoral and cellular response to COVID-19 vaccines in patients with IBD

A new study published in the preprint server medRxiv* aimed to evaluate the humoral and cellular response to COVID-19 vaccine in patients with IBD undergoing biologic or immunomodulatory therapy.

17 Sep 2021

Scientists identify new approach to overcome resistance to cancer immunotherapy

Hokkaido University scientists and colleagues in Japan have found a way that could help some patients overcome resistance to immunotherapy treatment for cancer. The approach, proven in mice experiments, was reported in the Journal for Immunotherapy of Cancer.

17 Sep 2021

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

A study evaluates the efficacy of a mAb to prevent disease progression in non-hospitalized persons with symptomatic SARS-CoV-2 infection.

17 Sep 2021

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

A team of international scientists and clinical experts have unraveled a new cell type in human skin that contributes to inflammatory skin diseases such as atopic dermatitis (AD) and psoriasis (PSO). Their study findings were published in the Journal of Experimental Medicine in September 2021.

17 Sep 2021

COVID-19 infections in Australian healthcare workers

A team of researchers performed state-wide SARS-CoV-2 genomic epidemiological investigations to recognize health care worker transmission dynamics and support optimizing healthcare system readiness for similar future outbreaks.

17 Sep 2021

Sex defining factors influence expression of ACE2 and other SARS-CoV-2 machinery

Results from this study provided evidence for the hypothesis that sex-defining factors influence the expression of ACE2 and other SARS CoV-2 machinery.

17 Sep 2021

Adenovirus-based nanoparticle vaccine elicits potent SARS-CoV-2 neutralizing antibody response

In a study available on the preprint server medRxiv*, researchers have created a vaccine designed to overcome issues associated with attenuated-virus vaccines.

17 Sep 2021

Skin cancer patients could have better prognosis with stronger T cell receptor signal strength

New research led by the University of Birmingham suggests that skin cancer patients could have a better prognosis if their T cells send messages from five specific genes in their immune response to drugs given to treat the disease.

17 Sep 2021

Discovery of biological response platform could provide opportunity to alleviate allergic inflammation

New discoveries about a built-in rapid reaction system that triggers inflammatory responses when people are exposed to allergens, such as insects, mites, and fungi, also may hold the keys to helping more people manage their allergies in years to come.

17 Sep 2021

Medical Science News

Researchers report on under-sequenced region of S gene of the SARS-CoV2 Delta variant

Specially designed lipid nanoparticles overcome resistance to anti-tumor immunotherapy

R37 MERIT Award supports innovative ovarian cancer research

Third dose of Pfizer-BioNTech vaccine increases neutralizing antibody levels against SARS-CoV-2

Higher white matter extracellular free-water related to cognitive dysfunction in lupus patients

Cross-species locomotion features shared by dopamine-deficient worms, mice, and humans

Increased presence of certain bacteria in the gut may indicate colon cancer risk

Research reveals a possible new treatment approach for pediatric rhabdomyosarcoma

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

Two-hour glucose tolerance test helps identify patients at heightened risk of cognitive decline

What pushed Israel out of herd immunity?

Humoral and cellular response to COVID-19 vaccines in patients with IBD

Scientists identify new approach to overcome resistance to cancer immunotherapy

mAb treatment can rapidly select for SARS-CoV-2 resistance, suggests study

Scientists discover new cell type in human skin that contributes to inflammatory skin diseases

COVID-19 infections in Australian healthcare workers

Sex defining factors influence expression of ACE2 and other SARS-CoV-2 machinery

Adenovirus-based nanoparticle vaccine elicits potent SARS-CoV-2 neutralizing antibody response

Skin cancer patients could have better prognosis with stronger T cell receptor signal strength

Discovery of biological response platform could provide opportunity to alleviate allergic inflammation

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Latest News